Skip to content

Public FDA record

Z-0755-2007: DiaSorin ETI-EBNA-G kits, Catalog No. P001607A. In vitro diagnostic. For the qualitative and/or semi-q

Recall record Z-0755-2007 for Diasorin Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0755-2007
Company in FDA record
Diasorin Inc.
FDA classification date
Apr 24, 2007
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

A lot to lot inconsistency was noted on kits of ETI EBNA G.

Source facts

Action
All consignees will be notified by phone followed by a notification letter sent by fax March 14, 2007. The distributors are instructed to forward the notification to the customers who have received the affected product.
Initiated
2007-03-14
Root cause
Other
Terminated
2007-07-15
Distribution
Nationwide and Canada.
Recall number
Z-0755-2007
Recall status
Terminated
CDRH record ID
51328
FDA classified
2007-04-24
Recall event number
37691

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗